Broker notes, analysis and comments
Advanced Oncotherapy plc (LON:AVO) goal is to deliver an affordable and novel PT system, called LIGHT, based on state-of-the-art technology developed originally at the world-renowned CERN. Over the past two..
The award of funding to Oncimmune Holdings plc (LON:ONC) by the ‘UK Research and Innovation Ideas to Address COVID-19’ project, leverages its proprietary ImmunoINSIGHTS technology to help in predicting disease..
Sumo Group plc (LON:SUMO) H1 results were ahead of our estimates. However, excluding select factors, profits were well above our expectations. Sumo’s strong underlying results positions it to outperform current..
Diurnal Group plc (LON:DNL) is a commercial-stage specialty pharmaceutical company focused on diseases of the endocrine system. Its products are targeting rare conditions where medical need is currently unmet, with..
Chamberlin plc (LON:CMH) recent trading update was most encouraging, considering these challenging times. The company continues to take appropriate operational strategic actions. The group has been financially de-risked, but financial..
News has been positive in the past few months. Surface Transforms plc (LON:SCE) announced a ground-breaking £27.5m contract award with a new OEM customer in mid-September. Trading has been more..
ICG Enterprise Trust plc (LON:ICGT) is the topic of conversation when Mark Thomas talks to DirectorsTalk. Mark explains why he called his report Defensive growth: explaining downside resilience, why PE..
Following a number of recent contracts wins GYG plc (LON:GYG) order book now stands at record levels, which we believe should give investors confidence in current forecasts. We leave our..
Shield Therapeutics plc (LON:STX) is a commercial-stage company delivering specialty products that address patients’ unmet medical needs, with an initial focus on treating iron deficiency (ID). Feraccru/Accrufer has been approved..
Arix Bioscience plc (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage..
City of London Investment Group plc (LON:CLIG) has announced its full-year results for FY’20. As previously indicated, over a volatile year, FUM grew to $5.51bn. This led to a 4%..
Diurnal Group plc (LON:DNL) is a commercial-stage specialty pharmaceutical company focused on diseases of the endocrine system. Its products are targeting rare conditions where medical need is currently unmet, with..
Filta Group Holdings plc (LON:FLTA) announced that it remained EBITDA-positive in 1H’20, despite most of its customers closing for part of the period. Business is returning as customers reopen, with..
JTC Group plc (LON:JTC) interims confirm the strength of JTC’s business model and cash conversion, and management has restated its medium-term guidance. Revenue rose 15.2% to £53.7m (1H19: £46.6m), reflecting..
SimplyBiz Group plc (LON:SBIZ) 1H results show digital acceleration as Defaqto and Intermediary Services have limited the impact of lockdown on revenue and EBITDA. Full year guidance remains at adj..
In this note, we explore Volta Finance plc (LON:VTA) portfolio positioning, increasing its CLO equity weight and reducing the CLO debt proportion. We show how this has helped deliver relative..
Post DWF Group plc (LON:DWF) results we consider key takeaways from the presentation and introduce our FY23 forecasts for the first time. YTD trading shows a clear recovery with the..
The most significant of several 2020 contract wins for Surface Transforms plc (LON:SCE) was announced on 14 September, from a new global customer, OEM 8. New order momentum is rising..
City of London Investment Group plc (LON:CLIG) results have beaten Zeus expectations at revenue, EPS and DPS. On 14 July CLIG provided an update which revealed $338m of net inflows..
Surface Transforms plc (LON:SCE) has announced a major contract win with a manufacturer of EVs. Lifetime revenue is estimated to be £27.5m. Our 2021e revenue forecast is lifted by c.80%..
